Samyang Business Group is striving to reshape itself into a global R&D innovation corporation, particularly in pharmaceuticals and bio sectors. 

The business group plans to establish an R&D center in the new satellite city of Pangyo, Seongnam, Gyeonggi Province, by 2014 with an investment of 120 billion won. The plan calls for relocating pharmaceuticals and bio research institutes in Seoul, Daejeon, Incheon, and the United States to Pangyo with the goal of creating synergetic effects in the R&D field and rapid growth in the pharmaceuticals business. 

Samyang Group aims to chalk up annual growth of more than 10 percent by aggressively investing in new business arenas. In particular, the business group plans to boost investments in the pharmaceutical sector. It has a target of becoming a global R&D innovation corporation after 2015. 

Samyang Group, celebrating its 88th anniversary, has found sustainable growth in such key businesses as chemicals and foods under the catchphrase, “Life’s Ingredients,” designed to make people’s lives more abundant and convenient. It strives to accelerate business portfolio diversification, sophistication, and globalization of its key business areas to ramp up its comp-etitiveness while aggressively making inroads into such fields as inform-ation/electronics materials and dining. 

The business group is striving to create value for the customer by establishing sustainable growth platforms and global manufacturing infrastructure by concentr-ating on the chemicals sector with its high growth potential, one of its key businesses.

Last year, Samyang Group established Samyang EP Hungary, a locally incorporated engineering plastics compound company in the Eastern European country, as part of its efforts to expand its overseas manufacturing foundation in the materials business arena. The establishment of Samyang EP Hungary, with an annual production capacity of 10,000 tons, has allowed the business group to complement its overseas manufacturing base that stretches from China to the United States and Eastern Europe.

Samyang Innochem, which started with the production of Bisphenol-A (BPA), which is used as a key ingredient to make engineering plastic polycarbonate, has secured a competitive edge in polycarbonate through vertical integration with Samyang Kasei Co. 

Samyang Group is redoubling its efforts to continuously secure more overseas materials production bases in such countries as China and the United States while concentrating on the development of new value-added materials. Samyang EMS, Samyang Group’s information electronics materials maker, is seeking to develop such new value-added materials as next-generation organic insulators.

Samyang’s Foods Business Unit is striving to offer value for customers centering around its integrated brand “Q.one.” Samyang is jointly conducting research on products tailored to meet customers’ needs based on such key ingredients as sugar, flour and starch sugar. Samyang is seeking to become a total solution provider by making the most of its own technology while ramping up competitiveness.